ALTRIA GROUP, INC. (MO) Earnings History

ALTRIA GROUP, INC. - Q1 2026 EarningsBeat

Filed at: Apr 30, 2026, 7:05 AM EDT|Read from source

EXECUTIVE SUMMARY

Altria Group reported a strong start to 2026, with adjusted diluted EPS growing 7.3% driven by higher pricing in its smokeable products segment and disciplined execution. The company reaffirmed its full-year guidance, signaling confidence despite macroeconomic uncertainties and moderated e-vapor industry growth.

POSITIVE HIGHLIGHTS

  • •

    Adjusted diluted EPS increased 7.3% to $1.32, driven by higher adjusted OCI and fewer shares outstanding.

    positive
  • •

    Net revenues increased 3.2% to $5.4 billion, primarily driven by higher net revenues in the smokeable products segment.

    positive
  • •

    Smokeable products segment reported OCI increased 8.3% and adjusted OCI increased 6.3%, with adjusted OCI margins increasing by 0.7 percentage points to 65.1%.

    positive
  • •

    Marlboro strengthened its position in the premium segment, with its share of the premium segment increasing 0.1 share points versus the prior year.

    positive

CONCERNS & RISKS

  • •

    Smokeable products segment reported domestic cigarette shipment volume decreased 2.4%, primarily driven by the industry’s decline rate.

    attention
  • •

    Oral tobacco products segment reported domestic shipment volume decreased 3.1%, primarily driven by retail share losses.

    attention
  • •

    Adjusted OCI margins for oral tobacco products decreased 1.8 percentage points to 67.4%.

    attention
  • •

    Marlboro retail share of the total cigarette category was 39.7%, a decrease of 1.4 share points versus the prior year.

    attention
  • •

    The cigarette industry discount retail share increased to 33.3%, indicating potential pressure on premium brands.

    attention

FINANCIAL METRICS

Revenue
Quarterly
$5.43B
+3.2%
Prior year: $5.26B
Net Income
Quarterly
$2.18B
+101.8%
Prior year: $1.08B
EPS (Diluted)
Quarterly
N/A
N/A
Operating Income
Quarterly
$2.96B
N/A
EPS (Basic)
Quarterly
N/A
N/A

MARGIN ANALYSIS

Gross Margin
Current Quarter
64.6%
Prior Year
61.8%
YoY Change
+279 bps
Operating Margin
Current Quarter
54.5%
Prior Year
34.0%
YoY Change
+2047 bps
Net Margin
Current Quarter
40.2%
Prior Year
20.5%
YoY Change
+1974 bps

Margin expansion indicates improving profitability and operational efficiency. Measured in basis points (bps): 100 bps = 1.0%.

REVENUE BY SEGMENT — Q1 2026 2026

VISUAL OVERVIEW

|
Smokeable Products
0.0%
N/A
Oral Tobacco Products
0.0%
N/A

DETAILED BREAKDOWN

|
SegmentCurrentPrior YrYoY% Total
Smokeable Products
N/A———
Oral Tobacco Products
N/A———
Total Revenue$0.00M——100.0%

Segment performance shows business unit health and growth drivers.

MANAGEMENT GUIDANCE

FY2026

Adjusted diluted EPS
$5.56—$5.72
Mid-point: $5.64
"Represents a growth rate of 2.5% to 5.5% from a base of $5.42 in 2025. More balanced growth expected between the first half and the second half of the year."

Forward-looking guidance is subject to change and does not constitute a guarantee. Actual results may differ materially from these estimates.

EARNINGS CALL —

Call date
2026-04-30
Tone
N/A
Hedge density
N/A
Deflection rate
N/A

SPECIAL ITEMS & ADJUSTMENTS

Q1 2026
NPM Adjustment Items
$9M
$0.00 per share
Q1 2026
Acquisition-related items
+$2M
$0.00 per share
Q1 2026
Asset impairment, exit and implementation costs
+$5M
$0.00 per share
Q1 2026
Tobacco and health and certain other litigation items
+$2M
$0.00 per share
Q1 2026
Amortization of intangibles
+$20M
$0.01 per share
Q1 2026
ABI-related special items
+$1M
$0.00 per share
Q1 2026
Cronos-related special items
+$2M
$0.00 per share
Q1 2026
Income tax items
+$12M
$0.01 per share
Q1 2025
Acquisition-related items
+$65M
$0.04 per share
Q1 2025
Asset impairment, exit and implementation costs
Non-cash impairment charge to the e-vapor reporting unit goodwill.
+$884M
$0.52 per share
Q1 2025
Tobacco and health and certain other litigation items
+$30M
$0.02 per share
Q1 2025
Amortization of intangibles
+$31M
$0.02 per share
Q1 2025
ABI-related special items
+$17M
$0.01 per share
Q1 2025
Cronos-related special items
$18M
$0.01 per share
Total Impact
+$1,044M$0.62 per share

Special items are non-recurring events that may distort period-over-period comparisons. Analysts typically adjust for these when calculating normalized earnings.

MANAGEMENT COMMENTARY

Delivered a strong start to the year, growing adjusted diluted EPS by 7.3% in the first quarter.

— ALTRIA GROUP, INC., Q1 2026 2026 Earnings Call

Highly cash-generative businesses supported significant returns to shareholders through dividends and share repurchases.

— ALTRIA GROUP, INC., Q1 2026 2026 Earnings Call

Smokeable products segment generated strong income growth, with Marlboro strengthening its position in the premium segment.

— ALTRIA GROUP, INC., Q1 2026 2026 Earnings Call

Commentary excerpts from earnings call transcripts provide management's perspective on performance, strategy, and outlook. Always review full transcripts for complete context.

OPERATIONAL METRICS

Marlboro Retail Share Pct
39.7
Prior year: 41.1
%
Domestic Cigarette Shipment Volume Millions
13.9K
-2.4% YoY
Prior year: 14.2K
sticks
On! Nicotine Pouch Share Pct
7.8
Prior year: 8.6
%
Total Oral Tobacco Products Shipment Volume Millions
169.9
-3.1% YoY
Prior year: 175.4
cans

Operational metrics provide insight into business drivers and customer engagement beyond traditional financial measures.

Related Research

Analysis

Every Headline Metric in Keurig Dr Pepper's Filing Is a Mirage

Analysis

Mondelez's Input Costs Outpaced Pricing by $729M — Where the Margin Went

Analysis

Altria's 101% Payout Ratio Masks 77% Free Cash Flow Coverage